It is the biggest shake-up of obesity treatment in NHS history, it has been claimed. From later this month, GPs will be able ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

According to the Mayo Clinic, most weight loss occurs within the first four to five months of use. Long-term use of weight loss drugs can lead to sustained weight decreases and improvements in overall ...

As global shortages hit Ozempic and Wegovy, rivals like Eli Lilly gain ground, including in India’s growing market for ...

The organization is providing trainers with information and education for how to coach clients taking the weight-loss ...

"We are introducing Wegovy (injectable Semaglutide 2.4 mg) this year, which offers full therapeutic strengths of semaglutide ...

By the end of the study, people on the maximum dose of Zepbound lost an average of about 50 ... lb (13.7 percent of their body weight) with Wegovy. More weight loss wasn’t the only advantage ...

Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...

Hers is a relatively new telehealth platform that offers prescription medications and customized support for weight loss. The ...

People who took Zepbound had greater reductions in waist circumference and body weight, a study found.Fact checked by Nick ...

By Sriparna Roy (Reuters) -After years of easily available, cheap copies of Eli Lilly's and Novo Nordisk's highly effective ...

The U.S. Food and Drug Administration has cracked down on compounded drugs, which were readily available while the patented ...